New Delhi: Bharat Biotech’s Kovacs, which is fully locally developed, is reported to be 81 per cent effective.
This assessment is in the third phase security test. Kovacs are capable of combating genetically modified viruses, says Dr. Bharat Biotech Chairman Krishna claimed everything.
The third phase of the experiment was performed on 25,800 people. The progress made by Kovacsin, which has been developed in the country in the last eight months, is a global achievement, said ICMR Director General Dr. Balram Bhargava responded.
President Ramnath Kovind received the first dose of the vaccine on Wednesday.
If you have any concerns or complaints regarding this article, please let us know and the article will be removed soon.